Epistemic responsibilities in the COVID-19 pandemic: Is a digital infosphere a friend or a foe

被引:7
|
作者
Curkovic, Marko [1 ,2 ]
Kosec, Andro [2 ,3 ]
Bedekovic, Marina Roje [4 ]
Bedekovic, Vladimir [2 ,3 ]
机构
[1] Univ Psychiat Hosp Vrapce, Bolnicka Cesta 32, Zagreb 10090, Croatia
[2] Univ Zagreb, Sch Med, Salata 2, Zagreb 10000, Croatia
[3] Univ Hosp Ctr Sestre Milosrdnice, Dept Otorhinolaryngol & Head & Neck Surg, Vinogradska Cesta 29, Zagreb 10000, Croatia
[4] Univ Hosp Ctr Sestre Milosrdnice, Dept Neurol, Vinogradska Cesta 29, Zagreb 10000, Croatia
关键词
Information; CoViD-19; Epistemology; Data science; Digital intermediary;
D O I
10.1016/j.jbi.2021.103709
中图分类号
TP39 [计算机的应用];
学科分类号
081203 ; 0835 ;
摘要
Digital technologies have a significant role in collecting, filtering and disseminating information, allowing for social, healthcare and economic activities even in the context of highly restrictive public health measures in the current COVID-19 pandemic. As personal contact is greatly reduced, they also create a shared informational landscape, allowing for a shared threat response. This is a difficult task, since truthfulness of content that leads to actionable knowledge is impossible to consistently validate. So, not only that curation of information is rarely congruent with pressing health issues, but digital spaces may also become fertile ground for misinformation and disinformation, contributing to the devastating effects of an infodemic. Digital intermediaries are useful exactly because their representation of reality is not a true construct, but a result of purposely curated information. However, they are active, dynamic epistemological agents with their own logic and aim. In dealing with a pandemic, we should reconsider the ways how our digital informational landscapes are created and sustained. This urges us to consider ethical governance of digital data curation and dissemination, alongside forms of control of the truthfulness and reach of its content. Some of the most fundamental issues in dealing with the COVID-19 pandemic, including the newly available vaccines are reliant on digital information and data sharing among experts, and the role of informing the general public. The need to create a reproducible, valid and truthful informational landscape is paramount, while allowing for free and rational, behavioral individual choices oriented toward preserving and promoting healthy behavior. These are issues at the heart of dealing with any pandemic, as well as a well-organized health care policy.
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Social media: friend or foe in the COVID-19 pandemic?
    Lima, Diego Laurentino
    de Medeiros Lopes, Maria Antonieta Albanez A.
    Brito, Ana Maria
    [J]. CLINICS, 2020, 75 : e1953
  • [2] NSAIDs in COVID-19, friend or foe?
    Victor, Robert
    Kelly, Richard
    Cockrill, Ryan
    Katrivesis, Karen
    Nelson, Corey
    Rajan, Govind
    [J]. ANAESTHESIA PAIN & INTENSIVE CARE, 2022, 26 (04) : 546 - 550
  • [3] Testosterone in COVID-19: Friend or Foe?
    Peter J. Niemann
    Heidi V. Goldstein
    [J]. Endocrine, 2021, 71 : 281 - 282
  • [4] Estrogen and COVID-19: friend or foe?
    Di Vincenzo, A.
    Andrisani, A.
    Vettor, R.
    Rossato, M.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 (07) : 934 - 934
  • [5] The COVID-19 facemask: Friend or foe?
    Hallock, Geoffrey G.
    [J]. JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY, 2021, 74 (05): : 1149 - 1150
  • [6] Testosterone in COVID-19: Friend or Foe?
    Niemann, Peter J.
    Goldstein, Heidi V.
    [J]. ENDOCRINE, 2021, 71 (02) : 281 - 282
  • [7] NSAIDs in COVID-19, friend or foe?
    Mahrous, Reham
    Abdelnasser, Amr
    Fouda, Raghda
    Morsy, Mohamed Abd Al Moniem
    Mandour, Omnia
    [J]. ANAESTHESIA PAIN & INTENSIVE CARE, 2023, 27 (01) : 119 - 122
  • [8] COVID-19 and diabetes: Is metformin a friend or foe?
    Ursini, Francesco
    Ciaffi, Jacopo
    Landini, Maria Paola
    Meliconi, Riccardo
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 164
  • [9] The complement system in COVID-19: friend and foe?
    Java, Anuja
    Apicelli, Anthony J.
    Liszewski, M. Kathryn
    Coler-Reilly, Ariella
    Atkinson, John P.
    Kim, Alfred H. J.
    Kulkarni, Hrishikesh S.
    [J]. JCI INSIGHT, 2020, 5 (15)
  • [10] Epinephrine use in COVID-19: friend or foe?
    Luo, Pan
    Liu, Dong
    Li, Juan
    [J]. EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2021, 28 (01)